Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W A Knight

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
Investigational New Drugs|January 1, 1983
Methyl-glyoxal bis guanyl hydrazone (methyl-GAG, MGBG) in lymphoma and Hodgkin's disease. A Phase II trial of the Southwest Oncology GroupW A Knight, C Fabian, J J Costanzi, et al.
Investigational New Drugs|January 1, 1983
Phase II evaluation of MGBG in non-small cell carcinoma of the lung. A Southwest Oncology Group studyR B Vance, W A Knight, T T Chen, et al.
Advances in Experimental Medicine and Biology|January 1, 1981
Estrogen receptor, a marker for human breast cancer differentiation and patient prognosisC K Osborne, E Fisher, C Redmond, et al.
Cancer Research|January 1, 1983
Multiple estrogen receptor assays in human breast cancerD F Hull, G M Clark, C K Osborne, et al.
Investigational New Drugs|January 1, 1983
Mitoxantrone in advanced breast cancer: a phase II trial of the Southwest Oncology GroupW A Knight, D D Von Hoff, J A Neidhart, et al.
Bone Marrow Transplantation|August 1, 1987
CFU-GEMM correlate with neutrophil and platelet recovery in patients receiving autologous marrow transplantation after high-dose melphalan chemotherapyG D Roodman, C F LeMaistre, G M Clark, et al.
Investigational New Drugs|January 1, 1990
Phase II trial of intravenous melphalan for metastatic colorectal carcinoma. A Southwest Oncology Group studyW A Knight, P Goodman, S A Taylor, et al.
Journal of Steroid Biochemistry|December 1, 1985
Adjuvant therapy for breast cancer with positive axillary nodes designed according to estrogen receptor statusS E Rivkin, W A Knight, R McDivitt, et al.
World Journal of Surgery|October 1, 1985
Adjuvant therapy for breast cancer with positive axillary nodes designed according to estrogen receptor statusS E Rivkin, W A Knight, R McDivitt, et al.
Investigational New Drugs|August 1, 1990
Phase II study of continuous infusion recombinant gamma interferon in renal carcinoma. A Southwest Oncology Group studyJ P Kuebler, P J Goodman, T D Brown, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
Investigational New Drugs|January 1, 1983
Methyl-glyoxal bis guanyl hydrazone (methyl-GAG, MGBG) in lymphoma and Hodgkin's disease. A Phase II trial of the Southwest Oncology GroupW A Knight, C Fabian, J J Costanzi, et al.
Investigational New Drugs|January 1, 1983
Phase II evaluation of MGBG in non-small cell carcinoma of the lung. A Southwest Oncology Group studyR B Vance, W A Knight, T T Chen, et al.
Advances in Experimental Medicine and Biology|January 1, 1981
Estrogen receptor, a marker for human breast cancer differentiation and patient prognosisC K Osborne, E Fisher, C Redmond, et al.
Cancer Research|January 1, 1983
Multiple estrogen receptor assays in human breast cancerD F Hull, G M Clark, C K Osborne, et al.
Investigational New Drugs|January 1, 1983
Mitoxantrone in advanced breast cancer: a phase II trial of the Southwest Oncology GroupW A Knight, D D Von Hoff, J A Neidhart, et al.
Bone Marrow Transplantation|August 1, 1987
CFU-GEMM correlate with neutrophil and platelet recovery in patients receiving autologous marrow transplantation after high-dose melphalan chemotherapyG D Roodman, C F LeMaistre, G M Clark, et al.
Investigational New Drugs|January 1, 1990
Phase II trial of intravenous melphalan for metastatic colorectal carcinoma. A Southwest Oncology Group studyW A Knight, P Goodman, S A Taylor, et al.
Journal of Steroid Biochemistry|December 1, 1985
Adjuvant therapy for breast cancer with positive axillary nodes designed according to estrogen receptor statusS E Rivkin, W A Knight, R McDivitt, et al.
World Journal of Surgery|October 1, 1985
Adjuvant therapy for breast cancer with positive axillary nodes designed according to estrogen receptor statusS E Rivkin, W A Knight, R McDivitt, et al.
Investigational New Drugs|August 1, 1990
Phase II study of continuous infusion recombinant gamma interferon in renal carcinoma. A Southwest Oncology Group studyJ P Kuebler, P J Goodman, T D Brown, et al.
Pageof 5